Search Results for: Cortisonici in gravidanza, gravi ripercussioni sul feto

Riduce il rischio di eventi cardiovascolari gravi specie nelle donne

Fimmg denuncia “gravi ritardi negli aggiornamenti degli elenchi

Fimmg denuncia “gravi ritardi negli aggiornamenti degli elenchi

Efficace anticorpo-farmaco. Curigliano: ‘Risposta intorno al 60%’

Rarissimo caso di severa osteoporosi transitoria in gravidanza

I risultati di studi sperimentali su animali dell’Ist. Ramazzini

La donna si è affidata al medico salernitano Raffaele Petta

E’ accaduto a Grado (Gorizia), operaio in gravi condizioni

Circulation, Volume 150, Issue Suppl_1, Page A4114436-A4114436, November 12, 2024. Background:Besides survival and recovery, women afflicted with peripartum cardiomyopathy (PPCM) harbor significant apprehension regarding the safety of future pregnancies. Current knowledge regarding the maternal and fetal outcomes in subsequent pregnancies among women with a history of PPCM is sparse. Likewise, there is insufficient medical evidence to provide guidance for women who opt to become pregnant again after experiencing PPCM.Research Questions:What is the feto-maternal prognosis of subsequent pregnancies following a history of PPCM?Aims:To describe the fetal and maternal outcomes of subsequent pregnancies following a history of PPCM.Methods:We included women from the Tanzania PPCM registry who had subsequent pregnancies after PPCM and assessed PPCM recurrence, maternal prognosis, and fetal outcomes.Results:Among the 870 survivors (286 of whom left ventricular function had returned to normal [group 1] and 584 with persistent left ventricular dysfunction [group 2]), subsequent pregnancies were observed in 121 (13.9%) women (78 in group 1 and 43 in group 2). Forty (51.3%) women in group 1 had PPCM relapse, and during a mean follow-up of 896 days, 34 (85.0%) had complete recovery, 3 (7.5%) had persistent heart failure, and 3 (7.5%) died. In group 2, four (9.3%) women had complete recovery, 32 (74.4%) had persistent heart failure, and 7 (16.3%) died. The infant mortality rate was 23.4%.Conclusions:After the initial pregnancy complicated by peripartum cardiomyopathy, subsequent pregnancies could lead to PPCM relapse and deleterious feto-maternal outcomes, including death.

Pro Vita, con la Ru-486 si velocizza l’omicidio del nascituro

La corteccia si riduce dell’1%, ma succede anche in pubertà e gravidanza